RELA and lymphoma: Further evidence that RelA T505A cells have fundamentally rewired their cell signalling pathways came from analysis of the intrinsic difference between Eμ-Myc WT and Eμ-Myc/RelaT505A lymphoma cells without CCT244747 treatment.